Olema Oncology
As the Associate Director, Regulatory Affairs CMC at Olema Oncology, you will develop and execute CMC regulatory strategies for product development and post-approval, ensuring alignment with global Health Authority requirements. The role involves collaborating with cross-functional teams to provide guidance on high-quality regulatory submissions and strategies, contributing to the organization’s mission of improving therapies for breast cancer and beyond.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2007
Olema Oncology is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for metastatic breast cancer and beyond. The company leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to advance its pipeline, including Phase 3 breast cancer trials and a KAT6 inhibitor program being evaluated in solid tumors and prostate cancer. Founded in 2006 and headquartered in San Francisco, California, Olema trades on Nasdaq under the ticker OLMA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Olema Oncology.
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Global Regulatory Affairs CMC Lead
City of Winnipeg
Regulatory Affairs CMC Responsible - Budapest
Opella
Global Regulatory Affairs CMC Lead
City of Pierre, South Dakota
Senior Director CMC Regulatory Affairs
Immunovant, Inc.
Director, Regulatory Affairs CMC
Taiho Oncology, Inc.
Regulatory Affairs CMC Professional
gloorlang